Drug
Azd-5069 clinical trials
Also written AZD5069.
- studies test it
- 13
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
- AZD5069
- 10
Studies by the year they started
13 studies that test it; most in 2010 (4)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 1
AstraZeneca (12) · Institute of Cancer Research, United Kingdom (1)
Often tested with
Tested in the same studies.
Danvatirsen (1) · Durvalumab (1) · Ketoconazole (1) · Enzalutamide (1)
Studies
Open first, then newest update. How each study uses azd-5069 is read from its arms, and is right about nine times in ten.
Testing it · 13
- Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & NeckCompletedPhase 1/2AstraZenecaNCT02499328Written as AZD5069
- Combination Study of AZD5069 and Enzalutamide.TerminatedPhase 1/2Institute of Cancer Research, United KingdomNCT03177187Written as AZD5069
- A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.CompletedPhase 2AstraZenecaNCT01704495Written as AZD5069
- Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069CompletedPhase 1AstraZenecaNCT01890148Written as AZD5069
- Evaluation of the Effect of AZD5069 in Patients With BronchiectasisCompletedPhase 2AstraZenecaNCT01255592Written as AZD5069
- A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2AstraZenecaNCT01233232Written as AZD5069 50mg
- Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.CompletedPhase 1AstraZenecaNCT01735240Written as AZD5069
- AZD5069 Neutrophil Function StudyCompletedPhase 1AstraZenecaNCT01480739Written as 100 mg (50 mg x 2) AZD5069
- This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral DoseCompletedPhase 1AstraZenecaNCT01083238Written as AZD5069
- Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069CompletedPhase 1AstraZenecaNCT01332903Written as [14C] AZD5069
- Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female SubjectsCompletedPhase 1AstraZenecaNCT00953888Written as AZD5069
- Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069CompletedPhase 1AstraZenecaNCT01100047Written as AZD5069
- A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT01051505Written as AZD5069
As the comparator · 1 — what is tested is compared with azd-5069
Codes
What other systems call azd-5069 · ClinicalTrials.gg INT000227
- UNII (FDA) 4ADT8JXB9SAZD-5069One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4ADT8JXB9S | AZD-5069 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.